Harpoon Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2018 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Harpoon Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2018 to Q1 2023.
  • Harpoon Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $26.6M, a 3107% increase year-over-year.
  • Harpoon Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $6.37M, a 94.3% decline from 2021.
  • Harpoon Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $112M, a 2285% increase from 2020.
  • Harpoon Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $4.68M, a 93.5% decline from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $26.6M +$25.8M +3107% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q1 2022 $830K -$107M -99.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $108M +$108M +40708% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $265K -$70.2M -99.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $70.5M +$70.5M +704970% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 $10K* Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.